Science Writer
Adaptive Biotechnologies recently received FDA Emergency Use Authorization (EUA) for T-Detect⢠COVID, a test that detects the unique T-cell signature specific to SARS-CoV-2. T-Detect COVID is the first clinical test launched from Adaptiveâs TCR-Antigen Map collaboration with Microsoft, highlighting the potential of using T cells in the blood to detect multiple diseases.
To learn more about T-Detect, its development and how it compares to antibody testing,
Technology Networks spoke to Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies. In this interview, Sudeb also discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases in the future.
Andreas Halvorsen Takes Stake In Mudrick Capital Acquisition Following Merger Announcement forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more
April 15, 2021 at 4:44 pm
Underwritten by
Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: tips@geekwire.com
Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. (Adaptive Biotechnologies Photo) Adaptive Biotechnologies co-founders and brothers Chad and Harlan Robins are among the directors of a new life sciences SPAC.
The blank check company is called CM Life Sciences III Inc. and listed on the NASDAQ starting April 7. The SPAC is targeting companies in “three separate areas of the life sciences industry that are often fragmented life sciences tools, synthetic biology and diagnostics.”
Some COVID-19 long haulers in Minnesota still lack diagnosis Few doctors available for complex, multi-system care of Long COVID patients April 4, 2021 12:27pm Text size Copy shortlink:
Andy Flosdorf never had a positive diagnosis for COVID-19, because tests were tightly rationed by the state when his symptoms started in late March 2020.
But the 51-year-old health care consultant in Minnetonka is still feeling the effects of COVID a year later fatigue, brain fog, episodic chest pains and headaches. His so-called Long COVID symptoms were recently diagnosed as chronic fatigue syndrome, another poorly understood disorder. There s tired, there s fatigue, there s exhaustion. And then there s something past that, which is where I ve been much of the year since, Flosdorf said.